Trial Outcomes & Findings for A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne. (NCT NCT02698436)
NCT ID: NCT02698436
Last Updated: 2018-01-23
Results Overview
COMPLETED
NA
103 participants
Baseline to 12 Weeks
2018-01-23
Participant Flow
Participant milestones
| Measure |
Acne Mask
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
Benzoyl Peroxide 2.5%
Apply test product to face once in the morning and once at night.
|
|---|---|---|
|
Overall Study
STARTED
|
59
|
58
|
|
Overall Study
COMPLETED
|
52
|
51
|
|
Overall Study
NOT COMPLETED
|
7
|
7
|
Reasons for withdrawal
| Measure |
Acne Mask
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
Benzoyl Peroxide 2.5%
Apply test product to face once in the morning and once at night.
|
|---|---|---|
|
Overall Study
Adverse Event
|
1
|
0
|
|
Overall Study
Withdrawal by Subject
|
3
|
3
|
|
Overall Study
Lost to Follow-up
|
2
|
4
|
|
Overall Study
Non-compliance with study regimen
|
1
|
0
|
Baseline Characteristics
A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne.
Baseline characteristics by cohort
| Measure |
Acne Mask
n=59 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide Treatment
n=58 Participants
Applied BPO treatment once daily
|
Total
n=117 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
17.8 years
STANDARD_DEVIATION 5.79 • n=5 Participants
|
18.7 years
STANDARD_DEVIATION 5.97 • n=7 Participants
|
18.2 years
STANDARD_DEVIATION 5.87 • n=5 Participants
|
|
Sex: Female, Male
Female
|
31 Participants
n=5 Participants
|
31 Participants
n=7 Participants
|
62 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
28 Participants
n=5 Participants
|
27 Participants
n=7 Participants
|
55 Participants
n=5 Participants
|
|
Region of Enrollment
USA
|
59 participants
n=5 Participants
|
58 participants
n=7 Participants
|
117 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Baseline to 12 WeeksPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Outcome measures
| Measure |
Acne Mask
n=55 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=54 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Percent Change of Global Face Total Acne Lesion Count From Baseline
|
-44 Percent change of acne lesion count
Interval -51.0 to -37.0
|
-54 Percent change of acne lesion count
Interval -61.0 to -45.0
|
SECONDARY outcome
Timeframe: Baseline to 1 WeekPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Outcome measures
| Measure |
Acne Mask
n=54 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=54 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 1
|
-19 Percent change of acne lesion count
Interval -25.0 to -13.0
|
-26 Percent change of acne lesion count
Interval -33.0 to -19.0
|
SECONDARY outcome
Timeframe: Baseline to 2 WeeksPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Outcome measures
| Measure |
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=52 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 2
|
-28 Percent change of acne lesion count
Interval -35.0 to -21.0
|
-42 Percent change of acne lesion count
Interval -48.0 to -35.0
|
SECONDARY outcome
Timeframe: Baseline to 4 WeeksPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Outcome measures
| Measure |
Acne Mask
n=54 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=52 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 4
|
-35 Percent change of acne lesion count
Interval -42.0 to -27.0
|
-46 Percent change of acne lesion count
Interval -53.0 to -39.0
|
SECONDARY outcome
Timeframe: Baseline to 8 WeeksPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Outcome measures
| Measure |
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=51 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 8
|
-40 Percent change of acne lesion count
Interval -46.0 to -33.0
|
-50 Percent change of acne lesion count
Interval -62.0 to -38.0
|
SECONDARY outcome
Timeframe: BaselinePopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Acne Lesion Count Total Global Face at Baseline
Outcome measures
| Measure |
Acne Mask
n=55 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=54 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Acne Lesion Counts Total Global Face - Baseline
|
47.2 Lesion Count
Standard Deviation 22.56
|
47.6 Lesion Count
Standard Deviation 23.22
|
SECONDARY outcome
Timeframe: 1 WeekPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Acne Lesion Count Total Global Face Week 1
Outcome measures
| Measure |
Acne Mask
n=54 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=54 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Acne Lesion Counts Total Global Face - Week 1
|
39.2 Lesion Count
Standard Deviation 22.5
|
36.8 Lesion Count
Standard Deviation 24.00
|
SECONDARY outcome
Timeframe: 2 WeeksPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Acne Lesion Count Total Global Face Week 2
Outcome measures
| Measure |
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=52 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Acne Lesion Counts Total Global Face - Week 2
|
35.3 Lesion Count
Standard Deviation 20.13
|
30.5 Lesion Count
Standard Deviation 22.88
|
SECONDARY outcome
Timeframe: 4 WeeksPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Acne Lesion Count Total Global Face Week 4
Outcome measures
| Measure |
Acne Mask
n=54 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=52 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Acne Lesion Counts Total Global Face - Week 4
|
30.5 Lesion Count
Standard Deviation 17.51
|
27.0 Lesion Count
Standard Deviation 19.76
|
SECONDARY outcome
Timeframe: 8 WeeksPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Acne Lesion Count Total Global Face Week 8
Outcome measures
| Measure |
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=51 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Acne Lesion Counts Total Global Face - Week 8
|
27.8 Lesion Count
Standard Deviation 16.06
|
26.4 Lesion Count
Standard Deviation 28.40
|
SECONDARY outcome
Timeframe: 12 WeeksPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Acne Lesion Count Total Global Face Week 12
Outcome measures
| Measure |
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=51 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Acne Lesion Counts Total Global Face - Week 12
|
24.8 Lesion Count
Standard Deviation 15.76
|
23.3 Lesion Count
Standard Deviation 20.91
|
SECONDARY outcome
Timeframe: BaselinePopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. 1. Almost Clear. A few scattered comedones and a few (less than five) small papules. 2. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. 3. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. 4. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. 5. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Outcome measures
| Measure |
Acne Mask
n=55 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=54 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Investigator Global Acne Assessment - Baseline
|
2.55 Score on a scale
Standard Deviation 0.529
|
2.51 Score on a scale
Standard Deviation 0.471
|
SECONDARY outcome
Timeframe: 1 WeekPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. 1. Almost Clear. A few scattered comedones and a few (less than five) small papules. 2. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. 3. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. 4. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. 5. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Outcome measures
| Measure |
Acne Mask
n=54 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=54 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Investigator Global Acne Assessment - Week 1
|
2.35 Score on a scale
Standard Deviation 0.538
|
2.34 Score on a scale
Standard Deviation 0.548
|
SECONDARY outcome
Timeframe: 2 WeeksPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. 1. Almost Clear. A few scattered comedones and a few (less than five) small papules. 2. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. 3. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. 4. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. 5. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Outcome measures
| Measure |
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=52 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Investigator Global Acne Assessment - Week 2
|
2.23 Score on a scale
Standard Deviation 0.598
|
2.11 Score on a scale
Standard Deviation 0.605
|
SECONDARY outcome
Timeframe: 4 WeeksPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. 1. Almost Clear. A few scattered comedones and a few (less than five) small papules. 2. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. 3. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. 4. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. 5. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Outcome measures
| Measure |
Acne Mask
n=54 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=52 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Investigator Global Acne Assessment - Week 4
|
2.08 Score on a scale
Standard Deviation 0.612
|
1.87 Score on a scale
Standard Deviation 0.650
|
SECONDARY outcome
Timeframe: 8 WeeksPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. 1. Almost Clear. A few scattered comedones and a few (less than five) small papules. 2. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. 3. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. 4. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. 5. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Outcome measures
| Measure |
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=51 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Investigator Global Acne Assessment - Week 8
|
1.88 Score on a scale
Standard Deviation 0.583
|
1.70 Score on a scale
Standard Deviation 0.775
|
SECONDARY outcome
Timeframe: 12 WeeksPopulation: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. 1. Almost Clear. A few scattered comedones and a few (less than five) small papules. 2. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. 3. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. 4. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. 5. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Outcome measures
| Measure |
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
|
2.5% Benzoyl Peroxide
n=51 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
|
|---|---|---|
|
Investigator Global Acne Assessment - Week 12
|
1.77 Score on a scale
Standard Deviation 0.660
|
1.59 Score on a scale
Standard Deviation 0.726
|
Adverse Events
Acne Mask
2.5% Benzoyl Peroxide Treatment
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place